Evidence map›Paper›PMID 42138317›Full record

ArticleChembiochem : a European journal of chemical biology2026

Structural and Dynamics Insights into Melatonin Binding to MT1 Receptor.

Clementina Acconcia, Antonella Paladino, Francesca Scebba, Maria Della Valle, Martina Montebuglio, Gaetano Malgieri, Carla Isernia, Roberto Fattorusso, Debora Angeloni, Stefano Comai and 1 more

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Structural and Dynamics Insights into Melatonin Binding to MT1 Receptor.Chembiochem : a European journal of chemical biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Clementina AcconciaDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "L. Vanvitelli", Caserta, Italy.
Antonella PaladinoInstitute of Biostructures and Bioimaging, CNR, Naples, Italy.ORCID https://orcid.org/0000-0002-9397-1572
Francesca ScebbaHealth Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
Maria Della ValleDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "L. Vanvitelli", Caserta, Italy.
Martina MontebuglioInstitute of Biostructures and Bioimaging, CNR, Naples, Italy.
Gaetano MalgieriDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "L. Vanvitelli", Caserta, Italy.
Carla IserniaDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "L. Vanvitelli", Caserta, Italy.
Roberto FattorussoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "L. Vanvitelli", Caserta, Italy.
Debora AngeloniHealth Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Pisa, Italy.
Stefano ComaiDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.ORCID https://orcid.org/0000-0002-5686-7194
Luigi RussoDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "L. Vanvitelli", Caserta, Italy.

Funding

CINECA HP10CBDF0CPRIN PNRR 2022 P2022YBTKF
6 · The paper itself

Abstract

Melatonin (MLT) (N-acetyl-5-methoxytryptamine), mainly acting through its two receptors MT1 and MT2, plays a crucial role in regulating circadian rhythms. In addition, MLT has antidepressant, anti-inflammatory, anti-tumor, antioxidant, locomotor activity-regulating, vascular, and neuroprotective effects. Despite recent reports on X-ray free-electron laser and cryo-EM structures of MT1 receptor in complex with agonists, such as agomelatine, 2-phenylmelatonin and ramelteon, a detailed high-resolution description of the MT1 binding by melatonin under near to native (physiological) conditions is still missing. To this aim, we used isolated cellular membranes overexpressing MT1 receptors to conduct a high-resolution nuclear magnetic resonance interaction study. Combined with computational methodologies such as homology modeling, molecular docking and molecular dynamics simulations, this approach provides significant structural and dynamical insights into the interaction between MT1 receptor and melatonin. We found that MLT interacts, through hydrophobic interactions, with the orthosteric binding pocket enhancing receptor motions that in turn facilitate local rearrangements in the cytoplasmic portion of MT1.

Indexed as

MelatoninReceptor, Melatonin, MT1Binding SitesHumansMolecular Docking SimulationMolecular Dynamics SimulationProtein BindingMelatoninReceptor, Melatonin, MT1melatoninmolecular dynamics simulationMT1‐receptoron‐cell membrane NMR spectroscopy

Identifiers

PMID42138317
PMCPMC13178210

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.